Evotec SE (XTER:EVT) Change In Inventory : €0.0 Mil (TTM As of Mar. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Evotec SE Change In Inventory?

Evotec SE's change in inventory for the quarter that ended in Mar. 2024 was €0.0 Mil. It means Evotec SE's inventory stayed the same from Dec. 2023 to Mar. 2024 .

Evotec SE's change in inventory for the fiscal year that ended in Dec. 2023 was €0.0 Mil. It means Evotec SE's inventory stayed the same from Dec. 2022 to Dec. 2023 .

Evotec SE's Total Inventories for the quarter that ended in Mar. 2024 was €31.8 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Evotec SE's Days Inventory for the quarter that ended in Mar. 2024 was 16.45.

Inventory Turnover measures how fast the company turns over its inventory within a year. Evotec SE's Inventory Turnover for the quarter that ended in Mar. 2024 was 5.55.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Evotec SE's Inventory-to-Revenue for the quarter that ended in Mar. 2024 was 0.15.

Evotec SE Change In Inventory Historical Data

The historical data trend for Evotec SE's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Evotec SE Change In Inventory Chart

Evotec SE Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Inventory

Get a 7-Day Free Trial

-1.36

-3.63

-11.65

-4.41

Evotec SE Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Inventory	Get a 7-Day Free Trial															-	-	-	-	-

Evotec SE Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

Evotec SE (XTER:EVT) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Evotec SE's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	31.364	/	173.966	*	365 / 4
	=	16.45

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Evotec SE's Inventory Turnover for the quarter that ended in Mar. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	173.966	/	31.364
	=	5.55

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Evotec SE's Inventory to Revenue for the quarter that ended in Mar. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	31.364	/	208.726
	=	0.15

Evotec SE Change In Inventory Related Terms

Thank you for viewing the detailed overview of Evotec SE's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Evotec SE (XTER:EVT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Evotec SE (XTER:EVT) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

EVO:USA EVOTF:USA 1EVT:Italy EVTd:UK 0IRF:UK EVT:Austria

Address

Essener Bogen 7, Manfred Eigen Campus, Hamburg, DEU, 22419

Website

https://www.evotec.com

Evotec SE is a drug discovery partnership company providing solutions to pharmaceutical & biotechnology companies, academic institutions as well as foundations, and not-for-profit organizations. The company offers its services in the area of neuronal diseases, diabetes & its complications, pain, inflammation, oncology, infectious diseases, respiratory & fibrosis, rare disease, and women's health. Its business segments are EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone drug discovery services on a typical fee-for-service basis or integrated drug discovery collaborations. The EVT Innovate segment develops drug discovery programs and assets, both internally and through academic collaborations. The majority of its revenue is derived from the EVT Execute segment.

Executives

Dr. Werner Lanthaler

Board of Directors

Evotec SE (XTER:EVT) Headlines

From GuruFocus

Eaton Vance Tax-Advantaged Dividend Income Fund January 2021 Distribution

By PRNewswire PRNewswire • 01-15-2021

EATON VANCE TAX ADVANTAGED DIVIDEND INCOME FUND's Dividend Analysis

By GuruFocus Research • 10-20-2023

EATON VANCE TAX ADVANTAGED DIVIDEND INCOME FUND's Dividend Analysis

By GuruFocus Research • 01-22-2024

Unveiling the Dividend Performance of EATON VANCE TAX ADVANTAGED DIVIDEND INCOME FUND (EVT)

By GuruFocus Research • 09-21-2023